{"id":2922,"date":"2020-06-03T17:35:22","date_gmt":"2020-06-03T17:35:22","guid":{"rendered":"https:\/\/mirm-pitt.net\/technologies\/?post_type=avada_portfolio&p=2922"},"modified":"2020-07-08T09:20:50","modified_gmt":"2020-07-08T09:20:50","slug":"use-of-slurp1-as-an-imunomodulatory-molecule-in-the-ocular-surface-2","status":"publish","type":"avada_portfolio","link":"https:\/\/mirm-pitt.net\/technologies\/patents\/use-of-slurp1-as-an-imunomodulatory-molecule-in-the-ocular-surface-2\/","title":{"rendered":"Use Of SLURP1 As An Imunomodulatory Molecule In The Ocular Surface"},"content":{"rendered":"

\u00a0Use Of SLURP1 As An Imunomodulatory Molecule In The Ocular Surface<\/h2>\n

Therapeutically Effective Amount Of A SLURP1 Polypeptide<\/p>\n<\/div>

<\/div><\/div><\/div>

Inventors:<\/strong> Shivalingappa Kottur Swamynathan: Sudha Swamynathan: Kristine Ann Gallegos Buela: Robert Lee Hendricks<\/p>\n

Patent Number:<\/strong> 14\/821,567<\/p>\n

\n
\n
\n

Abstract<\/h3>\n
\n
\n
Methods for treating inflammation are disclosed, such as for treating ocular inflammation. In some embodiments, the ocular inflammation is inflammation of an ocular surface, such as keratitis. The methods include administering to a subject with inflammation a therapeutically effective amount of SLURP1, or a nucleic acid encoding SLURP1, thereby treating the inflammation.<\/div>\n<\/section>\n<\/div>\n<\/section>\n<\/div>\n<\/div>\n<\/div>
<\/div>
<\/div>
<\/div>